Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
Clinical Immunology (Orlando, Fla.)|July 7, 2009
Immunization against angiotensins for the treatment of hypertensionPatrik Maurer, Martin F BachmannCurrent Opinion in Molecular Therapeutics|March 2, 2006
Therapeutic vaccines for nicotine dependencePatrik Maurer, Martin F BachmannExpert Opinion on Investigational Drugs|November 1, 2007
Vaccination against nicotine: an emerging therapy for tobacco dependencePatrik Maurer, Martin F BachmannEuropean Journal of Immunology|December 30, 2014
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory diseaseKiran Dallenbach, Patrik Maurer, Till Röhn, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
TLR9 signaling in B cells determines class switch recombination to IgG2aAndrea Jegerlehner, Patrik Maurer, Juliana Bessa, et al.Journal of Molecular Biology|November 15, 2011
Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibodyKaspars Tars, Svetlana Kotelovica, Gerd Lipowsky, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particlesGunther Spohn, Katrin Schwarz, Patrik Maurer, et al.European Journal of Immunology|November 8, 2011
Virus-like particles induce robust human T-helper cell responsesMarion Braun, Camilla Jandus, Patrik Maurer, et al.Proceedings of the National Academy of Sciences of the United States of America|September 25, 2008
Isolation of human monoclonal antibodies by mammalian cell displayRoger R Beerli, Monika Bauer, Regula B Buser, et al.Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.Pageof 25